|
⚲
|
| Keyboard |
| Danish Biotech SPV I P/S
✚
|
|
|---|---|
| CIK # | 0001591226 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001591226] | |
| 4 | [0001591226] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Omega Fund IV LP | |
| Danish Biotech SPV I P/S | |
| Zyla Life Sciences |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Zyla Life Sciences EGLT
Common Stock
|
2014-02-11 | Conversion | 438,364 | ||
|
Zyla Life Sciences EGLT
Common Stock
|
2014-02-11 | Conversion | 251,125 | ||
|
Zyla Life Sciences EGLT
Common Stock
|
2014-02-11 | Conversion | 523,799 | ||
|
Zyla Life Sciences EGLT
Common Stock
|
2014-02-11 | Option exercise | 112,500 | $0.00 | |
|
Zyla Life Sciences EGLT
Common Stock
|
2014-02-11 | Buy | 83,333 | $12.00 | 999,996 |
|
Zyla Life Sciences EGLT
Common Stock
|
2014-02-11 | Conversion | 321,077 | $6.00 | 1,926,462 |
|
Zyla Life Sciences EGLT
Common Stock
|
2014-02-11 | Buy | 156,250 | $12.00 | 1,875,000 |
|
Zyla Life Sciences EGLT
Common Stock
|
2014-02-11 | Option exercise | 60,000 | $0.00 | |
|
Zyla Life Sciences EGLT
Common Stock
|
2014-02-11 | Conversion | 171,241 | $6.00 | 1,027,446 |
|
Zyla Life Sciences EGLT
Common Stock
|
2014-02-11 | Conversion | 213,136 | $6.00 | 1,278,816 |
|
Zyla Life Sciences EGLT
Series B Preferred Stock · derivative
|
2014-02-11 | Conversion | 523,799 | $0.00 | |
|
Zyla Life Sciences EGLT
Series A-1 Preferred Stock · derivative
|
2014-02-11 | Conversion | 438,364 | $0.00 | |
|
Zyla Life Sciences EGLT
Senior Convertible Debt · derivative
|
2014-02-11 | Conversion | $0.00 | ||
|
Zyla Life Sciences EGLT
Warrants · derivative
|
2014-02-11 | Option exercise | 112,500 | $0.00 | |
|
Zyla Life Sciences EGLT
Subordinated Convertible Debt · derivative
|
2014-02-11 | Conversion | 60,000 | $0.00 | |
|
Zyla Life Sciences EGLT
Senior Convertible Debt · derivative
|
2014-02-11 | Conversion | $0.00 | ||
|
Zyla Life Sciences EGLT
Warrants · derivative
|
2014-02-11 | Option exercise | $0.00 | ||
|
Zyla Life Sciences EGLT
Series A-2 Preferred Stock · derivative
|
2014-02-11 | Conversion | 251,125 | $0.00 |